Background: Plant-based medicine is the 3rd most popular choice of both adults (11%) and children (6%) suffering from Asthma. While several plant-based formulations have been reported for the treatment of asthma in the past, many authors have published their reservations on clinical trials carried out using complementary and alternative medicines. Objectives: The authors desired to eliminate the shortcomings of the earlier clinical trials carried out by many investigators in a structured study. Therefore, a 12-week randomized double-blind placebo-controlled clinical study was conducted to investigate the efficacy of a plant-based formulation (DCBT4567-Astha-15) in comparison with oral salbutamol, salbutamol + theophylline and a matching placebo in patients with reversible asthma. Methods: Ninety-four patients between 15 and 50 years of age, showing 15% improvement in forced expiratory volume in 1 s (FEV1) 15 min after a bronchial challenge of inhaled salbutamol (200 µg) were recruited, and the end point of the study was determined as a 15% improvement in FEV1 and clinical symptoms like dyspnoea, wheezing, cough, expectoration, disability, sleep disturbances and respiration rate. Results: DCBT4567-Astha-15, salbutamol and salbutamol + theophylline patients showed statistically significant improvement in FEV1, while placebo patients did not show any improvement. Fifty percent of DCBT4567-Astha-15, 48% of salbutamol, 58% of salbutamol + theophylline and 26% of placebo patients showed the desired 15% improvement in FEV1. Improved mean FEV1 values at the end of the trial indicated that the salbutamol - theophylline combination was superior followed by salbutamol and DCBT4567-Astha-15. Clinical symptoms like dyspnoea, wheezing, cough, expectoration, disability, and sleep disturbances were significantly reduced in DCBT4567-Astha-15 patients compared to patients of the other three arms. Conclusions: DCBT4567-Astha-15 was as efficacious as salbutamol (12 mg/day) or salbutamol (12 mg/day) in combination with theophylline (200 mg/day) in the treatment of reversible asthmatics. Quality of life of patients also improved with DCBT4567-Astha-15 drug treatment.

1.
National Heart, Lung and Blood Institute: National Asthma Education Program Expert Panel Report: Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 1991;88:425–533.
2.
Goldstein MF, Chervinsky P: Efficacy and safety of doxofylline as compared to theophylline in chronic reversible asthma – a double-blind randomized placebo-controlled multicentre clinical trial. Med Sci Monit 2002;8:CR297–CR304.
3.
Ouksel H, Meslier N, Badatcheff-Coat A, Racineux JL: Influence of predicted FEV1 on bronchodilator response in asthmatic patients. Respiration 2003;70:54–59.
4.
Ernst E: Complementary therapies in asthma: What patients use? J Asthma 1998;35:667–671.
5.
Villani F, Comazzi R, De Maria P, Galimberti M: Effect of dietary supplementation with polyunsaturated fatty acids on bronchial hyperreactivity in subjects with seasonal asthma. Respiration 1998;65:265–269.
6.
Huntley A, Ernst E: Herbal medicines for asthma: a systematic review. Thorax 2000;55:925–929.
7.
Steurer-Stey C, Russi EW, Steurer J: Complementary and alternative medicine in asthma – do they work? Swiss Med Weekly 2002;132:338–344.
8.
Linde K, Jonas WB, Melchart D, Willich S: The methodological quality of randomized controlled trials of homoeopathy, herbal medicines and acupuncture. Int J Epidemiol 2001;30:526–531.
9.
Murali PM, Lakshmisubramanian S, Nalini K, Augustus GDPS, Perumal T, Krishnarajasekar OR, Rajasekaran S, Paramesh P, Deivanayagam CN: Proof of concept study of a herbal formulation for the treatment of asthma (abstract OP-02). Kochi, World Ayurvedic Congress, November 1–4, 2002.
10.
Deivanayagam CN, Sridhar CB, Rajasekaran S, Paramesh P, Krishnarajasekar OR, Perumal T, Vasudevan S, Lakshmisubramanian S, Nalini K, Murali PM: Promising plant-based formulation in the treatment of chronic obstructive pulmonary disease and asthma. New Delhi, National Symposium on Pulmonary and Critical Care Medicine, August 30 to September 1, 2002.
11.
Niphadkar PV, Ghamande AR, Shah MU, Mehta AK, Odak VV: Combination of salbutamol (2 mg)/theophylline (100 mg) in perennial bronchial asthma: a critical assessment. Lung India 1984;2:307–311.
12.
Murali PM, Rajasekaran S, Paramesh P, Krishnarajasekar OR, Vasudevan S, Nalini K, Lakshmisubramanian S, Deivanayagam CN: Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study. Respir Med, in press.
13.
Wood AJJ: Theophylline in asthma. N Engl J Med 1996;334:1380–1388.
14.
Antony S, Kuttan R, Kuttan G: Immunomodulatory activity of curcumin. Immunol Invest 1999;28:291–303.
15.
Kroes BH, Van den Berg AJJ, De Silva KTD, Labadie RP: Investigation of Nimba arishta, an immunomodulating ayurvedic drug obtained by fermentation. J Eur Ayurved Soc 1992;2:123–133.
16.
Puri A, Sahai R, Singh KL, Saxena RP, Tandon JS, Saxena KC: Immunostimulant activity of dry fruits and plant materials used in Indian traditional medical system for mothers after child birth and invalids. J Ethnopharmacol 2000;71:89–92.
17.
Atal CK, Sharma KL, Kaul A, Khajuria A: Immunomodulatory agents of plant origin. I. Preliminary screening. J Ethnopharmacol 1986;18:133–141.
18.
Srivasthva KC, Malhotra N: Acetyl eugenol, a component of oil of cloves (Syzygium aromaticum L.) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets. Prostoglandins Leukot Essent Fatty Acids 1991;42:73–81.
19.
Srinivas L, Shalini VK, Shylaja M: Turmerin: a water-soluble antioxidant peptide from turmeric. Arch Biochem Biophys 1992;292:617–623.
20.
Basu A, Chaudhuri AK: Preliminary studies on the anti-inflammatory and analgesic activities of Calotropis procera root extract. J Ethnopharmacol 1991;31:319–324.
21.
Sadique J, Chandra T, Thenmozhi V, Elango V: The anti-inflammatory activity of Enicostemma littorale and Mollugo cerviana. Biochem Med Metabol Biol 1987;37:167–176.
22.
Amin AH, Mehta DR: Bronchodilator alkaloid (vasicinone) from Adhatoda vasica Nees. Nature 1959;184:1317.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.